Strategic Advice and Regulatory Analysis

BlueReg experienced consultants can provide insight into all regulatory requirements for France:

• Drug Registration
• Early Access Programmes
• Post Marketing Authorisation Application (MAA) activities
• Promotional material review
• Quality systems and audits
• Interactions with healthcare professionals includingcompliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
• Pharmacovigilance
• Pricing and reimbursement

Our experts

Our team can also support you through the entire application process from development, to registration and post-approval management

Associated News